UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: EMLA-2525-Plaster-SE-AJ-RA

Generated Narrative: RegulatedAuthorization EMLA-2525-Plaster-SE-AJ-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/11834

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001718-00011834,http://ema.europa.eu/fhir/eurdId#1867; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Medicated plaster; indication = Emla plåster används vid: • Ytanestesi av intakt hud i samband med: o nålstick, t.ex. vid inläggning av perifer venkateter eller vid blodprovstagning o ytliga kirurgiska ingrepp, hos vuxna och den pediatriska populationen; legalStatusOfSupply = Medicinal product subject to medical prescription exempt for some pack sizes; classification = combinations

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 1993-05-28

holder: Organization Aspen Pharma Trading Limited

Cases

-TypeDate[x]
*First Authorisation1993-05-28